|
 |
| home > pmps > spring 2002 > needle-free injectors - advantages, current technologies and future innovations |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Advantages of Needle-Free Delivery Technology
As many as 10 billion injections of medications and vaccines are given to patients every year, administered in the vast majority of cases with a needle and syringe. While the simplicity and efficacy of this method of drug delivery is indisputable, it suffers from several drawbacks with respect to safety and acceptability. Prominent among these is the potential for needle-stick injuries, in which a health care provider is inadvertently pricked with a needle previously used for administering an injection. These injuries represent opportunities for the transmission of infectious disease, and therefore require extensive post-event surveillance and, in many cases, prophylactic treatment of the victim with expensive and toxic drugs. With estimates of the number of such injuries occurring annually in the US ranging as high as 800,000, needle-sticks represent both a serious safety problem and a considerable financial burden for the health care industry (1,2). An additional disadvantage of hypodermic needles is the significant expense required for their safe disposal. Finally, many patients are needle-averse, which can lead to significant problems with compliance (3).
Needle-free injection of medications and vaccines represents an alternative method of parenteral drug delivery that is as effective as needle and syringe but free of many of the aforementioned problems. Needle-free injection devices generate a fine stream of medication at high pressure, which penetrates the skin to deposit medication at the desired depth. The absence of hypodermic needles from the injection process removes the potential for needle-stick injuries and simplifies disposal. The rapidity of needle-free injections (typically a second or less) further enhances patient compliance and acceptance.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Line Clearance in Pharmaceutical Packaging & Manufacturing
5 February 2009, Manchester, UK
More info >>
|
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
|
